SCHEMBL8200261

SCHEMBL8200261

Cc1ccc(S(=O)(=O)NCC(Cc2ccccc2)NS(=O)(=O)c2ccc(C)cc2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 4/20 0.71
CA7 P43166 3/20 0.71
CA9 Q16790 3/20 0.60
CA1 P00915 3/20 0.60
CA12 O43570 2/20 0.60
CYP1A2 P05177 2/20 0.60
CYP3A4 P08684 2/20 0.60
ATM Q13315 2/20 0.60
CA4 P22748 1/20 0.60
L3MBTL1 Q9Y468 1/20 0.60
ALDH1A1 P00352 4/20 0.58
TSHR P16473 1/20 0.58
PLAU P00749 1/20 0.53
HPN P05981 1/20 0.53
GBA1 P04062 1/20 0.52
CTSL P07711 1/20 0.52
CYP19A1 P11511 1/20 0.51
MEN1 O00255 2/20 0.51
MAPT P10636 2/20 0.51
KMT2A Q03164 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21808621 0.84 CA2 (0.73) CA2CA7CA9CA1CA12
SCHEMBL18328186 0.84 CA2 (0.73) CA2CA7CA9CA1CA12
SCHEMBL19035749 0.84 CA2 (0.73) CA2CA7CA9CA1CA12
SCHEMBL18321207 0.84 CA2 (0.73) CA2CA7CA9CA1CA12
SCHEMBL14421867 0.83 MEN1 (0.56) CA2CA7CA1CYP1A2CYP3A4
SCHEMBL5002083 0.82 CA12 (0.61) CA2CA7CA9CA1CA12
SCHEMBL27850983 0.82 CA9 (0.61) CA2CA7CA9CA1CA12
SCHEMBL5002086 0.82 CA12 (0.61) CA2CA7CA9CA1CA12
SCHEMBL10332270 0.81 ALDH1A1 (0.67) CA2CA7CA9CA1CA12
SCHEMBL7325853 0.80 CA2 (0.67) CA2CA7CA9CA1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6084093-A SUBSTITUTED 1,4,7,10,13-PENTAAZACYCLOPENTADECANE MACROCYCLIC LIGANDS; MANGANESE COMPLEXES OF THE LIGAND ARE MIMICS OF SUPEROXIDE DISMUTASE; USEFUL AS THERAPEUTIC AGENTS FOR INFLAMMATORY DISEASES G. D. SEARLE & CO. (US) 2000-07-04 US disclosed
US-5874421-A Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide G. D. SEARLE & CO. (US) 1999-02-23 US disclosed
EP-0598753-B1 MANGANESE COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS EFFECTIVE AS CATALYSTS FOR DISMUTATING SUPEROXIDE MONSANTO CO (US) 1998-03-18 EP disclosed
US-5637578-A AGENTS FOR INFLAMMATION, ISCHEMIC/REPERFUSION INJURY, STROKE, ATHEROSCLEROSIS, AND HYPERTENSION MONSANTO COMPANY 1997-06-10 US disclosed
US-5610293-A TREATMENT OF INFLAMMATORY DISEASES, ISCHEMIC/REPERFUSION INJURY, STROKE, ATHERSCLEROSIS, HYPERTENSION MONSANTO COMPANY (US) 1997-03-11 US disclosed
EP-0598753-A1 MANGANESE COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS EFFECTIVE AS CATALYSTS FOR DISMUTATING SUPEROXIDE MONSANTO COMPANY (US) 1994-06-01 EP disclosed
WO-1993002090-A1 MANGANESE COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS EFFECTIVE AS CATALYSTS FOR DISMUTATING SUPEROXIDE MONSANTO COMPANY (US) 1993-02-04 WO disclosed
EP-0524161-A1 Manganese complexes of nitrogen containing macrocyclic ligands effective as catalysts for dismutating superoxide MONSANTO COMPANY (US) 1993-01-20 EP disclosed